G3139, a BCL-2 antisense oligo-nucleotide, in AML.
Marcucci
G
G
Division of Hematology-Oncology, Department of Medicine, The Ohio State University, Columbus, OH
Stock
W
W
Dai
G
G
Klisovic
M I
MI
Maharry
K
K
Shen
T
T
Liu
S
S
Sher
D A
DA
Lucas
D
D
Zwiebel
A
A
Larson
R A
RA
Caligiuri
M A
MA
Bloomfield
C D
CD
Chan
K K
KK
Grever
M R
MR
Byrd
J C
JC
D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics; D016376:Oligonucleotides, Antisense / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D012333:RNA, Messenger / Q000187:drug effects / Q000235:genetics; D013873:Thionucleotides / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use*
D016376:Oligonucleotides, Antisense; D012333:RNA, Messenger; D013873:Thionucleotides; C408162:oblimersen